TMC Acquisitions LLC, doing business as Tailor Made Compounding, is voluntarily recalling 108 vials of injectable Semaglutide/Cyanocobalamin and NAD+. The recall includes 9 vials of Semaglutide/Cyanocobalamin (2mg/0.4mg/mL) and 99 vials of NAD+ (200mg/ml). These medications were recalled because the firm cannot guarantee they are sterile. No incidents or injuries have been reported to date. Consumers who have these products should stop using them and contact their healthcare provider.
Injectable medications that are not sterile can introduce bacteria or other contaminants directly into the bloodstream or tissue. This poses a significant risk of serious, potentially life-threatening infections at the injection site or throughout the body.
You have 2 options:
Recall #: D-1105-2023
Recall #: D-1106-2023
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.